Overview
  • Broad-spectrum fluoroquinolone indicated for the management of diseases associated with bacteria susceptible to enrofloxacin
  • Targets gram-positive and gram-negative bacteria, including those causing dermal, urinary and respiratory tract infections
  • Chewable tablets are double scored for accurate dosing
  • For dogs and cats

22.7 mg

68.0 mg

136 mg